BIOGEN INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Biogen Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Biogen Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $62.5M.
  • Biogen Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $292M, a 98.6% increase year-over-year.
  • Biogen Inc. annual Income Tax Expense (Benefit) for 2023 was $135M, a 78.6% decline from 2022.
  • Biogen Inc. annual Income Tax Expense (Benefit) for 2022 was $633M, a 1105% increase from 2021.
  • Biogen Inc. annual Income Tax Expense (Benefit) for 2021 was $52.5M, a 94.7% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $292M $62.5M +$135M Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $156M $115M +$300K +0.26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $156M $71.4M +$20.7M +40.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $135M $42.7M -$11.6M -21.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $147M -$72.9M -$309M -131% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $456M $115M -$102M -47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $558M $50.7M -$74.9M -59.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $633M $54.3M -$389M -87.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $1.02B $236M +$262M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $760M $217M +$626M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $134M $126M +$81.4M +184% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $52.5M $443M +$430M +3208% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 -$377M -$25.9M -$267M -111% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 -$111M -$409M -$855M -192% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $745M $44.2M -$248M -84.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $992M $13.4M -$263M -95.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $1.26B $241M +$29.5M +14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $1.23B $446M +$198M +79.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $1.03B $292M -$131M -30.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $1.16B $276M -$194M -41.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $1.35B $211M -$159M -42.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $1.51B $248M -$15.6M -5.92% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $1.53B $423M +$100M +31% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $1.43B $470M -$1.1B -70% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $2.52B $370M -$14M -3.65% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $2.54B $264M -$5.9M -2.19% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $2.54B $323M +$83.3M +34.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 $2.46B $1.57B +$1.38B +723% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q3 2017 $1.08B $384M +$46.8M +13.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-23
Q2 2017 $1.04B $270M -$84M -23.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-24
Q1 2017 $1.12B $239M -$117M -32.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 $1.24B $190M -$66.8M -26% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q3 2016 $1.3B $337M +$6.9M +2.09% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 $1.3B $354M +$61.1M +20.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-25
Q1 2016 $1.24B $356M +$74.5M +26.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-25
Q4 2015 $1.16B $257M -$11.1M -4.14% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q3 2015 $1.17B $330M +$55.3M +20.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 $1.12B $293M +$24M +8.93% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-21
Q1 2015 $1.09B $282M +$103M +58% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-21
Q4 2014 $990M $268M +$77.9M +41% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-02
Q3 2014 $912M $275M +$88.7M +47.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-21
Q2 2014 $823M $269M +$109M +68.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
Q1 2014 $714M $178M +$113M +172% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-24
Q4 2013 $601M $190M +$53.9M +39.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-03
Q3 2013 $547M $186M +$55.1M +42% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-22
Q2 2013 $492M $159M +$38.1M +31.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-23
Q1 2013 $454M $65.5M -$16.6M -20.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-23
Q4 2012 $471M $136M +$31.4M +29.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-04
Q3 2012 $439M $131M +$3.94M +3.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $435M $121M +$26M +27.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $409M $82.1M -$35.3M -30.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $445M $105M +$26.2M +33.2% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-06
Q3 2011 $418M $127M +$52.1M +69.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-25
Q2 2011 $366M $95M -$7.21M -7.05% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-24
Q1 2011 $373M $117M +$42.2M +56% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q4 2010 $331M $78.8M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-05
Q3 2010 $75M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $102M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
Q1 2010 $75.3M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.